2791 - 2800 of 8580 Results
Title
Year
-
OPENTitle: Parkinson’s Disease is Predominantly a Genetic DiseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 14Issue #: 3Start Page: 467End Page: 482Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-230376Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd230376?id=journal-of-parkinsons-disease%2Fjpd230376Citation Count: 9
-
RESTRICTEDTitle: The Human AffectomeJournal Name: Neuroscience & Biobehavioral ReviewsPublisher: Elsevier BVVol: 158Issue #:Start Page: 105450End Page: 105450Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.neubiorev.2023.105450Best OA location URL: https://doi.org/10.1016/j.neubiorev.2023.105450Citation Count: 8
-
OPENTitle: Perspectives of People At-Risk on Parkinson’s Prevention ResearchJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 14Issue #: 3Start Page: 399End Page: 414Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-230436Citation Count: 5
-
RESTRICTEDTitle: Chaperone-mediated autophagy: machinery, regulation and biological consequencesJournal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 68Issue #: 5Start Page: 749End Page: 763Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00018-010-0565-6Citation Count: 111
-
RESTRICTEDTitle: Molecular imaging of levodopa-induced dyskinesiasJournal Name: Cellular and Molecular Life SciencesPublisher: Springer Science and Business Media LLCVol: 72Issue #: 11Start Page: 2107End Page: 2117Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00018-015-1854-xCitation Count: 17
- Genetic testing in adults with neurologic disorders: indications, approach, and clinical impacts2023RESTRICTEDTitle: Genetic testing in adults with neurologic disorders: indications, approach, and clinical impactsJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 271Issue #: 2Start Page: 733End Page: 747Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-023-12058-6Citation Count: 1
- Proinflammatory cytokines levels in sepsis and healthy volunteers, and tumor necrosis factor-alpha associated sepsis mortality: A systematic review and meta-analysis2022RESTRICTEDTitle: Proinflammatory cytokines levels in sepsis and healthy volunteers, and tumor necrosis factor-alpha associated sepsis mortality: A systematic review and meta-analysisJournal Name: CytokinePublisher: Elsevier BVVol: 158Issue #:Start Page: 156006End Page: 156006Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.cyto.2022.156006Best OA location URL: https://doi.org/10.1016/j.cyto.2022.156006Citation Count: 25
- Smaller total and subregional cerebellar volumes in posttraumatic stress disorder: a mega-analysis by the ENIGMA-PGC PTSD workgroup2024RESTRICTEDTitle: Smaller total and subregional cerebellar volumes in posttraumatic stress disorder: a mega-analysis by the ENIGMA-PGC PTSD workgroupJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 29Issue #: 3Start Page: 611End Page: 623Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41380-023-02352-0Best OA location URL: https://www.nature.com/articles/s41380-023-02352-0.pdfCitation Count: 0
- The 2022 symposium on dementia and brain aging in low‐ and middle‐income countries: Highlights on research, diagnosis, care, and impact2024RESTRICTEDTitle: The 2022 symposium on dementia and brain aging in low‐ and middle‐income countries: Highlights on research, diagnosis, care, and impactJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 20Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.13836Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.13836Citation Count: 0
-
RESTRICTEDTitle: Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2024 UpdateJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 14Issue #: 5Start Page: 1End Page: 14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-240272Citation Count: 0